| For: | Jahagirdar V, Ahmed M, Fatima I, Ali H, Alba L, Helzberg JH, Cummings LS, Wilkinson M, Forster J, Likhitsup A. Prostaglandin E1 administration post liver transplantation and renal outcomes: A retrospective single center experience. World J Transplant 2024; 14(4): 98797 [PMID: 39697460 DOI: 10.5500/wjt.v14.i4.98797] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3230/full/v14/i4/98797.htm |
| Number | Citing Articles |
| 1 |
Xuya Kang, Han Jin, Yaoyao Zheng, Kejia Zhang, Guangxuan Zhu, Xinying Wang, Chaojie Xu, Chi Zhang, Lei He, Zhuoyang Yu, Genlong Xue, Lijun Liu, Yan Zhang, Lin Yao, Erdan Dong, Yahan Liu. The heterogeneity of dopamine-mediated vasodilation in human intrarenal arteries. Journal of Advanced Research 2026; doi: 10.1016/j.jare.2026.06.020
|
| 2 |
Ziqing Shen, Yanfen Zhang, Rongwei Zhao, Xiaowen Yang, Jiarong Guo, Mingyan Dong, Ting Ma, Songyan Ma, Na Sai, Zhiheng Dong. Therapeutic effects of alprostadil on CCl4-induced hepatic fibrosis in rats and investigation of its molecular mechanisms. Molecular and Cellular Biochemistry 2026; 481(7) doi: 10.1007/s11010-026-05607-w
|
| 3 |
Siyuan Yao, Jerzy W. Kupiec-Weglinski. Advancing our understanding of molecular targets for hepatic ischemia-reperfusion injury therapy. Expert Opinion on Therapeutic Targets 2026; 30(4) doi: 10.1080/14728222.2026.2671677
|